Novel psychoactive substances in young adults with and without psychiatric comorbidities.
Giovanni MartinottiMatteo LupiTiziano AcciavattiEduardo CinosiRita SantacroceMaria Salvina SignorelliLaura BandiniGiulia LisiDiego QuattronePaola CiambroneAndrea AgugliaFederica PinnaSalvatore CalòLuigi JaniriMassimo di GiannantonioPublished in: BioMed research international (2014)
The use of novel psychoactive substances in a young psychiatric population appears to be a frequent phenomenon, probably still underestimated. Therefore, careful and constant monitoring and accurate evaluations of possible clinical effects related to their use are necessary.